Aurobindo Pharma merger & restructuring announcements

Every Aurobindo Pharma merger & restructuring announcement on NSE and BSE, newest first, each with its own page.

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

1 Oct 2026 12:47 IST NSE

Merger & Restructuring Aurobindo Pharma Ltd AUROPHARMA

Aurobindo Pharma Merger & Restructuring Worth ₹33.8 Cr

Aurobindo Pharma's subsidiary, Apitoria Pharma, completed a 20% stake dilution in A1 Biochem Labs. Dr. Rajendra Gadikota subscribed to securities worth ₹33.80 Crore.

Value: ₹33.80 Cr

Open announcement → Read the filing ↗

12 Sep 2026 12:41 IST NSE

Merger & Restructuring Aurobindo Pharma Ltd AUROPHARMA

Aurobindo Pharma Merger & Restructuring Worth ₹9.5 Cr

Aurobindo Pharma's subsidiary, A1 Biochem Labs (India), invested USD 1,000,000 (approx. ₹9.5 Crore) to incorporate and capitalize a new US subsidiary, A1 Biochem USA Inc.

Value: ₹9.50 Cr

Open announcement → Read the filing ↗

1 Sep 2026 10:10 IST NSE

Merger & Restructuring Aurobindo Pharma Ltd AUROPHARMA

Aurobindo Pharma Merger & Restructuring Worth ₹5 Cr

Aurobindo Pharma's subsidiary, Apitoria Pharma, incorporated a new wholly owned subsidiary named Avogent Lifesciences. The initial capital subscription for this pharmaceutical entity is Rs. 5 Crore.

Value: ₹5.00 Cr

Open announcement → Read the filing ↗